<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Metabolic syndrome pathophysiology</title>
    <subTitle>the role of essential fatty acids</subTitle>
  </titleInfo>
  <name type="personal">
    <namePart>Das, Undurti N.</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
    <role>
      <roleTerm type="text">author.</roleTerm>
    </role>
  </name>
  <typeOfResource/>
  <originInfo>
    <issuance/>
  </originInfo>
  <physicalDescription>
    <extent>xiv, 268 pages : illustrations :</extent>
  </physicalDescription>
  <tableOfContents>History, definition, and diagnosis of the metabolic syndrome -- Insulin resistance in the metabolic syndrome -- Is it necessary to redefine the metabolic syndrome? -- Is insulin resistance a disorder of the brain? -- Obesity -- Perinatal nutrition and obesity -- Essential hypertension -- Dietary factors and hypertension -- Is hypertension a disorder of the brain? -- Type 2 diabetes mellitus -- Pathophysiology of type 2 diabetes mellitus with particular reference to hypothalamus -- Insulin and insulin receptors in the brain and their role in the pathogenesis of obesity and type 2 diabetes mellitus -- Insulin, endothelial nitric oxide, and the metabolic syndrome -- Obesity, type 2 diabetes mellitus, the metabolic syndrome, and the gut microbiota -- Is it possible that the metabolic syndrome originates in the perinatal period? -- Essential fatty acids : biochemistry and physiology -- Role of EFAs/PUFAs in brain growth and development and pathophysiology of the metabolic syndrome -- EFAs/PUFAs and their metabolites in insulin resistance -- EFAs/PUFAs and atherosclerosis.</tableOfContents>
  <note type="statement of responsibility">Undurti N. Das.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>Metabolic syndrome</topic>
    <topic>Pathophysiology</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Essential fatty acids</topic>
    <topic>Pathophysiology</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Unsaturated fatty acids</topic>
    <topic>Pathophysiology</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Insulin resistance</topic>
    <topic>Pathophysiology</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Type 2 diabetes</topic>
    <topic>Pathophysiology</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Brain</topic>
    <topic>Metabolism</topic>
  </subject>
  <subject authority="mesh">
    <topic>Metabolic Syndrome X</topic>
    <topic>physiopathology</topic>
  </subject>
  <subject authority="mesh">
    <topic>Brain</topic>
    <topic>physiopathology</topic>
  </subject>
  <subject authority="mesh">
    <topic>Fatty Acids, Essential</topic>
    <topic>pharmacology</topic>
  </subject>
  <subject authority="mesh">
    <topic>Fatty Acids, Essential</topic>
    <topic>physiology</topic>
  </subject>
  <subject authority="mesh">
    <topic>Fatty Acids, Unsaturated</topic>
    <topic>pharmacology</topic>
  </subject>
  <subject authority="mesh">
    <topic>Fatty Acids, Unsaturated</topic>
    <topic>physiology</topic>
  </subject>
  <classification authority="lcc">RC662 DAS 2010</classification>
  <identifier type="isbn">9780813815534</identifier>
  <identifier type="isbn">0813815533</identifier>
  <recordInfo>
    <recordChangeDate encoding="iso8601">20260531101416.0</recordChangeDate>
  </recordInfo>
</mods>
